ETF Investing: Biotech stocks on pace to snap 8-day win streak as warnings abound

ShutterstockNEW YORK (MarketWatch)—Biotech stocks slumped Monday, with the largest biotech ETF down about 1.7% and on track to snap an eight-session winning streak.The slide comes as some market watchers warn that biotech shares have enjoyed a great run-up and could be due for a drop.“Biotech must be slaughtered” is how a post over at the iBankCoin blog puts it.How low […]

Are Large-Cap Biotech Stocks in a Bubble? – InvestorPlace

No one likes the “B” word, but it’s worth asking whether we’re seeing one in large-cap biotech stocks right now.Source: © first glance, it seems to be a legitimate question given how well the sector has performed in the past year. The iShares Nasdaq Biotechnology Index (ETF) (NASDAQ:IBB) has gained nearly 70% since the low of mid-April 2014, and it […]

Biotech Stocks Soar Amid Positive News – Biogen Idec Inc …

Related BIIBStifel Downgrades Biogen Amid Concerns Of Lack Of Upcoming Data, OvervaluationBenzinga’s Top #PreMarket LosersIs Biogen Stock Worth Considering Right Now?(Seeking Alpha)Related GILDGilead Shares Tumble On Drug Warning; Baird Says BuyBenzinga’s Top #PreMarket LosersSeeking Alpha’s Biotech Weekly: Biogen’s Plaque Attack, Amgen Or Gilead?, And More(Seeking Alpha)A number of biotech stocks were soaring in Friday’s premarket following positive news.Biogen Idec Inc […]

3 Big Cap Biotechs That Could Trounce Gilead Sciences This Year

Gilead Sciences’ (NASDAQ: GILD) blockbuster launches of the hepatitis C drugs Sovaldi and Harvoni resulted in its revenue jumping 122% in 2014, but with Gilead Sciences facing tough comparisons this year, these three big-cap biotech stocks may be in better positions to see their shares climb in 2015


3 Big Cap Biotechs That Could Trounce Gilead Sciences This Year

See which stocks […]

The 4 Biggest Biotech Stocks In The Market – Celgene Corporation …

When the market gets a little sketchy, investors might tend to prefer the “blue chip” companies vs. the smaller companies due to the perceived safety in the bigger names.To isolate those bigger names, the most common method is by searching for companies with the largest market capitalization.Market cap is defined as the total dollar market value of all of a […]

Forget Gilead Sciences (GILD), Buy These Biotech Stocks Instead …

Gilead, without a doubt, has proven itself to be a leader in the biotechnology industry. The stock has had an extremely bullish pattern over the last four years, growing over 400% in stock price since March 2011. However, over the last 6 months, the stock has seen a loss of about 5%.In fact, there has been a considerable amount of […]

There Go the Biotechs as Generic Approval Rocks Amgen

By Ben LevisohnBiotech stocks like Gilead Sciences (GILD) and Amgen (AMGN) have been a great place to be for investors. Now, the approval of the first biosimilar in the U.S. is raising concerns that biotech profits will decline–and causing their stocks to tumble. Citigroup’s Andrew Baum and team explain why:
Bloomberg News

Approval of Sandoz’s Zarxio, with full extrapolation across indications and lack […]

Top 5 Biotech Stocks That The Smart Money Doesn't Like – Benzinga

Preface: The biotech stocks considered for this review were confined to those over $10 per share that traded at least 500K shares a day based on a 90-day average.For the longest time it seemed that for every new high the S&P 500 hit, biotech stocks, as measured by the iShares Nasdaq Biotechnology Index (NASDAQ: IBB), hit two new highs.Biotechnology […]

The 5 hottest ETFs in the world

Biotech companies are restoring sight to the blind, curing hepatitis C and fighting off HIV.As they save lives, biotech companies are simultaneously making a lot of money for investors.That’s why the hottest ETFs (exchange-traded funds) on the planet since the bull market began in March 2009 invest in biotech companies.The First Trust NYSE Arca Biotech ETF (FBT) has skyrocketed more […]

Big Biotech Poised for Big 2015?

By Ben LevisohnLeerink’s Howard Liang and team think 2015 will be another good year for biotech stocks like Gilead Sciences (GILD), Celgene (CELG), Amgen (AMGN ) and Alexion Pharmaceuticals (ALXN). They explain why:
Boston Globe via Getty Images

Biotech fundamentals appear strong, and could attract and broaden investor interest in the sector. Ongoing and upcoming product launches could be among the fastest […]